Lexby WheresMyMEPGet Pro free

Amgen Inc has 15 disclosed EU lobbying meetings from 2024-10-10 to 2026-05-26: 4 with the European Commission and 11 with Members of the European Parliament. Source: EU Transparency Register no. 42243575237-50, Commission disclosures and MEP declarations. Methodology

Amgen Inc

EU lobbying footprint — who they meet, and on what.

Register no.
42243575237-50 ↗
Disclosed meetings
15 (4 Commission · 11 MEP)
Period
2024-10-10 → 2026-05-26

Declared fields of interest: Budget · Business and industry · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Education and training · Employment and social affairs · Enlargement · Environment · External relations

Lobbying profile

as declared 2026-03-18
Category
Companies & groups
Legal status
Corporation
Declared lobbying cost
€1,000,000
Lobbying FTEs
3.7
Members
3
LobbyFacts / Transparency Register source ↗

At a glance

Most-met policy areas
  • Health2
Commission officials
  • Laszlo Kristoffy1
  • Carmen Laplaza Santos1
  • Marco La Marca1
  • Peter Van Kemseke1

Disclosed meetings

Newest first. EC = European Commission, EP = Member of the European Parliament.

Lobbying in these areas

Who lobbies on Healthcare & Medical Devices →

Frequently asked

How many EU lobbying meetings has Amgen Inc disclosed?

Amgen Inc (EU Transparency Register no. 42243575237-50) appears in 15 disclosed meetings with EU officials and MEPs between 2024-10-10 and 2026-05-26: 4 with the European Commission and 11 with Members of the European Parliament.

What does Amgen Inc lobby on?

Amgen Inc's disclosed EU meetings most often concern Health. Every meeting and its topic is listed with its official source on this page.

Who does Amgen Inc meet in Brussels?

Across its disclosed meetings, Amgen Inc has met Commission officials including Laszlo Kristoffy, Carmen Laplaza Santos, Marco La Marca, and MEPs including TER LAAK Ingeborg, ZINGARETTI Nicola, GONZÁLEZ CASARES Nicolás. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See how this affects your company →Ask Lex about Amgen Inc →